09:08 AM EDT, 03/22/2024 (MT Newswires) -- Health care stocks were steady pre-bell Friday, with the iShares Biotechnology ETF ( IBB ) unchanged and the Health Care Select Sector SPDR Fund (XLV) marginally lower recently.

Eton Pharmaceuticals ( ETON ) was up almost 13% after saying it acquired the US rights to Relief Therapeutics' medical formula product, PKU GOLIKE, for the dietary management of phenylketonuria.

Outlook Therapeutics ( OTLK ) was rallying past 44% after saying its investigational ophthalmic formulation of bevacizumab to treat wet age-related macular degeneration, ONS-5010, received a positive opinion from a European Medicines Agency panel.

Stevanato Group (STVN) was down more than 1% after it priced its upsized public offering of 12.7 million shares at $26 each for expected gross proceeds of about $330 million.